ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ANIP ANI Pharmaceuticals

Market Closed 11-15 16:00:00 EST

56.58

-2.33

-3.96%

盘后56.58

+0.000.00%

16:20 EST

High59.32	Low56.02	Vol293.06K
Open59.00	D1 Closing58.91	Amplitude5.60%
Mkt Cap1.19B	Tradable Cap908.24M	Total Shares21.04M
T/O16.79M	T/O Rate1.83%	Tradable Shares16.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals","latestPrice":56.58,"timestamp":1731704400000,"preClose":58.91,"halted":0,"volume":293055,"hourTrading":{"tag":"盘后","latestPrice":56.58,"preClose":56.58,"latestTime":"16:20 EST","volume":4858,"amount":274865.64,"timestamp":1731705602738},"delay":0,"floatShares":16052400,"shares":21040933,"eps":1.183342,"marketStatus":"Market Closed","change":-2.33,"latestTime":"11-15 16:00:00 EST","open":59,"high":59.32,"low":56.02,"amount":16793246.584241,"amplitude":0.056018,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.183342,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1064980800000,"exchange":"NASDAQ","adjPreClose":58.91,"preHourTrading":{"tag":"盘前","latestPrice":59.92,"preClose":58.91,"latestTime":"09:00 EST","volume":9,"amount":534.14001,"timestamp":1731679202074},"postHourTrading":{"tag":"盘后","latestPrice":56.58,"preClose":56.58,"latestTime":"16:20 EST","volume":4858,"amount":274865.64,"timestamp":1731705602738},"volumeRatio":0.8751703726399286,"impliedVol":0.4303,"impliedVolPercentile":0.6151},"requestUrl":"/m/hq/s/ANIP","defaultTab":"news","newsList":[{"id":"2483389510","title":"Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483389510","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483389510?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:40","pubTimestamp":1731595214,"startTime":"0","endTime":"0","summary":"Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's \"Value\" category. Stocks with \"A\" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.One stock to keep an eye on is ANI Pharmaceut","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-undervaluing-ani-pharmaceuticals-anip-144014661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ISBC","ANIP","BK4211"],"gpt_icon":0},{"id":"2482077736","title":"ANI Pharmaceuticals Price Target Maintained With a $94.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482077736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482077736?lang=en_us&edition=fundamental","pubTime":"2024-11-11 23:32","pubTimestamp":1731339120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANIP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 10:32 ET (15:32 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2482783428","title":"Truist Financial Remains a Hold on ANI Pharmaceuticals (ANIP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482783428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482783428?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:29","pubTimestamp":1731328152,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Les Sulewski maintained a Hold rating on ANI Pharmaceuticals (ANIP – Research Report) today and set a price target of $62....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-ani-pharmaceuticals-anip?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-ani-pharmaceuticals-anip?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2482202436","title":"ANI Pharmaceuticals: Buy Rating Backed by Consistent Revenue Growth, Strategic Acquisitions, and Strong Market Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2482202436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482202436?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:27","pubTimestamp":1731324444,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Oren Livnat from...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ani-pharmaceuticals-buy-rating-backed-by-consistent-revenue-growth-strategic-acquisitions-and-strong-market-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ani-pharmaceuticals-buy-rating-backed-by-consistent-revenue-growth-strategic-acquisitions-and-strong-market-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANIP"],"gpt_icon":0},{"id":"2482202552","title":"ANI Pharmaceuticals Inc : Guggenheim Raises Target Price to $84 From $83","url":"https://stock-news.laohu8.com/highlight/detail?id=2482202552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482202552?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:24","pubTimestamp":1731324279,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nFWN3MI0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2482220469","title":"U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2482220469","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482220469?lang=en_us&edition=fundamental","pubTime":"2024-11-11 15:08","pubTimestamp":1731308903,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva SystemsNov 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4N3MI0GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYBR","ACT","ALRM","AFL","CACI","BAX","LU2286300806.USD","EL","CELH","CPAY","EVH","CUZ","VEEV","CBT","ATMU","BILL","LU1861559042.SGD","LU1559883803.SGD","CNA","APA","CERT","BHF","AKAM","CRK","CTKB","LU0342679015.USD","DOCS","EXR","TKNO","CUBE","LU0472753341.HKD","AMP","ADPT","COTY","BK4121","BOW","CIM","LU2125909916.SGD","BRX","ENPH","CRL","BMBL","BK4097","IE00BVYPNW00.USD","ANIP","CRBG","EXAS","DKNG"],"gpt_icon":1},{"id":"2482266760","title":"ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2482266760","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482266760?lang=en_us&edition=fundamental","pubTime":"2024-11-10 21:30","pubTimestamp":1731245437,"startTime":"0","endTime":"0","summary":"NasdaqGM:ANIP Earnings and Revenue Growth November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.7%. Earnings per share  missed analyst estimates significantly.Looking ahead, revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 5.6% from a week ago.We don't want to rain on the parade too much, but we did also find 1 warning sign for ANI Pharmaceuticals that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-pharmaceuticals-third-quarter-2024-133037202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"2482089448","title":"ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482089448","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482089448?lang=en_us&edition=fundamental","pubTime":"2024-11-09 17:00","pubTimestamp":1731142826,"startTime":"0","endTime":"0","summary":"Total Revenue: $148.3 million, an increase of 13% over Q3 2023.Cortrophin Gel Revenue: $52.6 million, up 77% over Q3 2023.Generics Revenue: $78.2 million, an increase of 11% over Q3 2023.Gross Margin: 60%, a decrease of 3.9 points from the prior year period.Full Year 2024 Revenue Guidance: Raised to $594 million to $602 million.Full Year 2024 Cortrophin Gel Revenue Guidance: Raised to $196 million to $200 million.Full Year 2024 Adjusted Non-GAAP EBITDA Guidance: Raised to $149 million to $153 million.Full Year 2024 Adjusted Non-GAAP EPS Guidance: Raised to $4.90 to $5.05.GuruFocus has detected 4 Warning Signs with ANIP.Cortrophin Gel revenues increased by 77% year-over-year, with strong demand across multiple specialties, indicating a robust growth trajectory.Revenues from established brands and other segments decreased by 57% year-over-year, impacting overall revenue growth.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-pharmaceuticals-inc-anip-q3-090026651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"2482494184","title":"ANI Pharmaceuticals’ Record Growth and Strategic Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2482494184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482494184?lang=en_us&edition=fundamental","pubTime":"2024-11-09 12:21","pubTimestamp":1731126111,"startTime":"0","endTime":"0","summary":"Ani Pharmaceuticals ( ($ANIP) ) has released its Q3 earnings. Here is a breakdown of the information Ani Pharmaceuticals presented to its investors...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ani-pharmaceuticals-record-growth-and-strategic-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ani-pharmaceuticals-record-growth-and-strategic-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANIP","BK4007"],"gpt_icon":0},{"id":"2482893664","title":"ANI Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482893664","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482893664?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:21","pubTimestamp":1731082868,"startTime":"0","endTime":"0","summary":"* ANI Pharmaceuticals Inc    reported quarterly adjusted earnings of $1.34 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.27.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2482482606","title":"Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2482482606","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482482606?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:00","pubTimestamp":1731078005,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals  reported $148.33 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 12.5%. EPS of $1.34 for the same period compares to $1.27 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $143.97 million, representing a surprise of +3.03%. The company delivered an EPS surprise of +22.94%, with the consensus EPS estimate being $1.09.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how ANI performed in the just reported quarter in terms of the metrics most widely monitored and pr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compared-estimates-ani-anip-q3-150005222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"1143061227","title":"Stock Track | ANI Pharmaceuticals Soars on Record Q3 Results, Raised Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1143061227","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143061227?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:12","pubTimestamp":1731075158,"startTime":"0","endTime":"0","summary":"Shares of ANI Pharmaceuticals  surged 8.77% in pre-market trading on November 8, 2024, fueled by the company's impressive third-quarter 2024 financial results and raised full-year guidance.ANI reported record quarterly net revenue of $148.3 million, reflecting a robust 12.5% year-over-year increase. The company's flagship product, Cortrophin Gel, continued its remarkable performance, with net revenue soaring 76.8% to $52.6 million, driven by strong demand and increasing market share across multi","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ANIP"],"gpt_icon":0},{"id":"2481021191","title":"ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481021191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481021191?lang=en_us&edition=fundamental","pubTime":"2024-11-08 21:05","pubTimestamp":1731071103,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals  came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 22.94%. A quarter ago, it was expected that this drugmaker would post earnings of $0.93 per share when it actually produced earnings of $1.02, delivering a surprise of 9.68%.Over the last four quarters, the company has surpassed consensus EPS estimates four times.ANI , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $148.33 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.03%. This compares to year-ago revenues of $131.83 million. The company has topped consensus revenue estimates four times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-pharmaceuticals-anip-q3-earnings-130503008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"2481179704","title":"ANI Pharmaceuticals' Q3 Adjusted Earnings, Net Revenue Rise; Fiscal 2024 Outlook Lifted","url":"https://stock-news.laohu8.com/highlight/detail?id=2481179704","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481179704?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:20","pubTimestamp":1731068405,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals  reported Q3 adjusted earnings Friday of $1.34 per diluted share, up from $1.27 a year earlier.Analysts polled by Capital IQ expected $1.09.Net revenue for the quarter ended Sept. 30 was $148.3 million, compared with $131.8 million a year earlier.Analysts polled by Capital IQ expected $144.4 million.The company said it now expects fiscal 2024 adjusted earnings of $4.90 to $5.05 per diluted share, compared with its previous guidance range of $4.38 to $4.82.Net revenue for the year is now anticipated in the range of $594 million to $602 million, compared with $540 million to $560 million anticipated previously, it added.Analysts polled by Capital IQ expect $4.72 in normalized EPS on revenue of $590.3 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANIP"],"gpt_icon":0},{"id":"2481417694","title":"ANI Pharmaceuticals Expects 2024 Adjusted EPS Of $4.90-$5.05 Versus Prior Guidance Of $4.38-$4.82 Versus Consensus Of $4.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2481417694","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481417694?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:02","pubTimestamp":1731067332,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals Expects 2024 Adjusted EPS Of $4.90-$5.05 Versus Prior Guidance Of $4.38-$4.82 Versus Consensus Of $4.72","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41840281/ani-pharmaceuticals-expects-2024-adjusted-eps-of-4-90-5-05-versus-prior-guidance-of-4-38-4-82-versu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2481176844","title":"ANI Pharmaceuticals Expects 2024 Revenues Of $594M-$602M Versus Prior Guidance Of $540M-$560M Versus Consensus Of $590.315M","url":"https://stock-news.laohu8.com/highlight/detail?id=2481176844","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481176844?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:00","pubTimestamp":1731067241,"startTime":"0","endTime":"0","summary":"Revised Full Year 2024 Guidance:The Company is updating its full year 2024 guidance for the combined organization, which includes the anticipated results of Alimera from September 16, 2024.Revised Full Year 2024","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41840212/ani-pharmaceuticals-expects-2024-revenues-of-594m-602m-versus-prior-guidance-of-540m-560m-versus-co","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2481177514","title":"ANI: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2481177514","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481177514?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:58","pubTimestamp":1731067131,"startTime":"0","endTime":"0","summary":"BAUDETTE, Minn.  — BAUDETTE, Minn.  — ANI Pharmaceuticals Inc.  on Friday reported a third-quarter loss of $24.2 million, after reporting a profit in the same period a year earlier.The Baudette, Minnesota-based company said it had a loss of $1.27 per share. Earnings, adjusted for one-time gains and costs, were $1.34 per share.The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.09 per share.The drugmaker posted revenue of $148.3 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $144 million.ANI expects full-year revenue in the range of $594 million to $602 million.ANI shares have climbed almost 6% since the beginning of the year. The stock has declined 8.5% in the last 12 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-q3-earnings-snapshot-115851545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"2481799231","title":"ANI Pharmaceuticals Non-GAAP EPS of $1.34 beats by $0.25, revenue of $148.33M beats by $3.96M","url":"https://stock-news.laohu8.com/highlight/detail?id=2481799231","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481799231?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:52","pubTimestamp":1731066770,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals press release  (NASDAQ:ANIP): Q3  Non-GAAP EPS of $1.34  beats by $0.25.\nRevenue of $148.33M (+12.5% Y/Y)  beats by $3.96M.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4265050-ani-pharmaceuticals-non-gaap-eps-of-1_34-beats-0_25-revenue-of-148_33m-beats-3_96m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["ANIP"],"gpt_icon":0},{"id":"2481803175","title":"ANI Pharmaceuticals Q3 2024 Adj EPS $1.34 Beats $1.09 Estimate, Sales $148.33M Beat $144.35M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481803175","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481803175?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:51","pubTimestamp":1731066716,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.09 by 22.94 percent. This is a 5.51 percent increase over earnings of $1.27 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41839929/ani-pharmaceuticals-q3-2024-adj-eps-1-34-beats-1-09-estimate-sales-148-33m-beat-144-35m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ANI Pharmaceuticals Q3 2024 Adj EPS $1.34 Beats $1.09 Estimate, Sales $148.33M Beat $144.35M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2481753381","title":"BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2481753381","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481753381?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:51","pubTimestamp":1731066674,"startTime":"0","endTime":"0","summary":"BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.09\n\n\nNov 08 (Reuters) - ANI Pharmaceuticals Q3 revenue USD 148.332 million vs. IBES estimate USD 144.4 million.\n\noutlook FY adjusted EPS USD 4.9-5.05\noutlook FY adjusted EBITDA USD 149-153 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nPLX3F6FD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0791},{"period":"1month","weight":-0.0516},{"period":"3month","weight":-0.0573},{"period":"6month","weight":-0.079},{"period":"1year","weight":0.104},{"period":"ytd","weight":0.0261}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.064659},{"month":2,"riseRate":0.416667,"avgChangeRate":0.0136},{"month":3,"riseRate":0.375,"avgChangeRate":-0.029311},{"month":4,"riseRate":0.541667,"avgChangeRate":0.137911},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.019321},{"month":6,"riseRate":0.64,"avgChangeRate":0.036553},{"month":7,"riseRate":0.44,"avgChangeRate":-0.036667},{"month":8,"riseRate":0.44,"avgChangeRate":-0.010558},{"month":9,"riseRate":0.44,"avgChangeRate":0.023941},{"month":10,"riseRate":0.48,"avgChangeRate":-0.035044},{"month":11,"riseRate":0.6,"avgChangeRate":0.08493},{"month":12,"riseRate":0.458333,"avgChangeRate":-0.053943}],"exchange":"NASDAQ","name":"ANI Pharmaceuticals","nameEN":"ANI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ANI Pharmaceuticals(ANIP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ANI Pharmaceuticals,ANIP,ANI Pharmaceuticals股票,ANI Pharmaceuticals股票老虎,ANI Pharmaceuticals股票老虎国际,ANI Pharmaceuticals行情,ANI Pharmaceuticals股票行情,ANI Pharmaceuticals股价,ANI Pharmaceuticals股市,ANI Pharmaceuticals股票价格,ANI Pharmaceuticals股票交易,ANI Pharmaceuticals股票购买,ANI Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ANI Pharmaceuticals(ANIP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction